CCS
BAK icon

Concentric Capital Strategies’s Braskem BAK Stock Holding History

Concentric Capital Strategies’s Portfolio BAK Stock Details BAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,273
Closed -$99.4K – 282
2023
Q4 		$99.4K Buy
+11,273
New +$86.1K 0.01% 212

Other funds holding BAK

OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
MPM
MBB Public Markets Chicago, Illinois $839M AUM 20.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Concentric Capital Strategies's BAK Position: Q1 2024 in Review

Concentric Capital Strategies sold out of Braskem (BAK) in Q1 2024, closing a stake of 11,273 shares — an estimated $99.4K sold.

Concentric Capital Strategies first reported a position in BAK in Q4 2023 and held it in 1 quarter. The position peaked at $99.4K in Q4 2023. 50 funds tracked by Wall St. Rank hold BAK as of Q1 2024.

  • Concentric Capital Strategies reported no remaining Braskem position as of Q1 2024 after selling out during the quarter.
  • Concentric Capital Strategies sold 11,273 Braskem shares in Q1 2024, an estimated $99.4K.
  • Concentric Capital Strategies first reported a position in Braskem in Q4 2023 and held it in 1 quarter.
  • Concentric Capital Strategies's Braskem position peaked at $99.4K in Q4 2023.
  • 50 funds tracked by Wall St. Rank held Braskem as of Q1 2024.

Based on Concentric Capital Strategies's 13F filing for Q1 2024, filed 14 May 2024.